Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA. - Heinke A; Warter A; Nagel ID; Agnihotri A; Mehta NN; Galang CMB; Deussen DN; Bartsch DG; Cheng L; Ferreyra HA; Freeman WR (International journal of retina and vitreous, 2025)